Prognostic prediction of novel risk scores (AML-DRG and AML-HCT-CR) in acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation

We aimed to validate and prove the novel risk score models of acute myeloid leukemia (AML)-specific disease risk group (AML-DRG) and AML-Hematopoietic Cell Transplant-composite risk (AML-HCT-CR) in patients with acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplantation (A...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Weijie, Li, Xiaoning, Zhang, Ran, Bian, Zhilei, Zhang, Suping, Li, Li, Xing, Haizhou, Liu, Changfeng, Xie, Xinsheng, Jiang, Zhongxing, Fang, Xiaosheng, Wan, Dingming, Yu, Jifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643536/
https://www.ncbi.nlm.nih.gov/pubmed/36347881
http://dx.doi.org/10.1038/s41598-022-20735-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643536/
https://www.ncbi.nlm.nih.gov/pubmed/36347881
http://dx.doi.org/10.1038/s41598-022-20735-1

Ejemplares similares